Literature DB >> 8861970

Human immunodeficiency virus type 1 reverse transcriptase: role of Tyr115 in deoxynucleotide binding and misinsertion fidelity of DNA synthesis.

A M Martín-Hernández1, E Domingo, L Menéndez-Arias.   

Abstract

Tyr115 is located in the vicinity of the polymerase catalytic site of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. Site-directed mutagenesis was used to generate variant enzymes having Phe, Trp, Ala, Ser, Asp or Lys instead of Tyr115. The substitution of Tyr115 by Phe renders a fully active polymerase, displaying similar kinetic parameters, processivity and misinsertion fidelity of DNA synthesis as the wild-type enzyme. In contrast, the replacement of Tyr by Asp or Lys produced enzymes with a very low polymerase activity. The activity of the variant enzymes having Trp, Ala or Ser instead of Tyr115 was reduced significantly, particularly when poly(rA)484 was used as template. This effect was caused by a dramatic increase in the Km value for dTTP, and was detected using a DNA template mimicking a proviral HIV-1 gag sequence. Misinsertion fidelity assays revealed that mutants Y115W, Y115A and Y115S had a higher misinsertion efficiency than the wild-type reverse transcriptase. The low fidelity of these mutants appears to be related to nucleotide recognition rather than altered DNA-DNA template-primer interactions. The effects observed on the steady state kinetic constants, processivity and fidelity were mediated by the 66 kDa subunit, as demonstrated using chimeric heterodimers with the Y115A substitution in either p66 or p51.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8861970      PMCID: PMC452167     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  59 in total

1.  The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1.

Authors:  D W Rodgers; S J Gamblin; B A Harris; S Ray; J S Culp; B Hellmig; D J Woolf; C Debouck; S C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

2.  Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.

Authors:  R Esnouf; J Ren; C Ross; Y Jones; D Stammers; D Stuart
Journal:  Nat Struct Biol       Date:  1995-04

3.  Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy.

Authors:  I Nájera; A Holguín; M E Quiñones-Mateu; M A Muñoz-Fernández; R Nájera; C López-Galíndez; E Domingo
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

4.  Sensitivity of wild-type human immunodeficiency virus type 1 reverse transcriptase to dideoxynucleotides depends on template length; the sensitivity of drug-resistant mutants does not.

Authors:  P L Boyer; C Tantillo; A Jacobo-Molina; R G Nanni; J Ding; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

5.  Human immunodeficiency virus-1 reverse transcriptase heterodimer stability.

Authors:  J Lebowitz; S Kar; E Braswell; S McPherson; D L Richard
Journal:  Protein Sci       Date:  1994-09       Impact factor: 6.725

6.  Glutamine 151 participates in the substrate dNTP binding function of HIV-1 reverse transcriptase.

Authors:  S G Sarafianos; V N Pandey; N Kaushik; M J Modak
Journal:  Biochemistry       Date:  1995-05-30       Impact factor: 3.162

7.  Insights into DNA polymerization mechanisms from structure and function analysis of HIV-1 reverse transcriptase.

Authors:  P H Patel; A Jacobo-Molina; J Ding; C Tantillo; A D Clark; R Raag; R G Nanni; S H Hughes; E Arnold
Journal:  Biochemistry       Date:  1995-04-25       Impact factor: 3.162

8.  Misincorporation and mispaired primer extension by human immunodeficiency virus reverse transcriptase.

Authors:  S Zinnen; J C Hsieh; P Modrich
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

9.  Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.

Authors:  P L Boyer; A L Ferris; P Clark; J Whitmer; P Frank; C Tantillo; E Arnold; S H Hughes
Journal:  J Mol Biol       Date:  1994-10-28       Impact factor: 5.469

Review 10.  Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance.

Authors:  C Tantillo; J Ding; A Jacobo-Molina; R G Nanni; P L Boyer; S H Hughes; R Pauwels; K Andries; P A Janssen; E Arnold
Journal:  J Mol Biol       Date:  1994-10-28       Impact factor: 5.469

View more
  35 in total

1.  Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription.

Authors:  J K Pfeiffer; R S Topping; N H Shin; A Telesnitsky
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Analysis of mutations at positions 115 and 116 in the dNTP binding site of HIV-1 reverse transcriptase.

Authors:  P L Boyer; S G Sarafianos; E Arnold; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

3.  The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.

Authors:  Matthew M Schuckmann; Bruno Marchand; Atsuko Hachiya; Eiichi N Kodama; Karen A Kirby; Kamalendra Singh; Stefan G Sarafianos
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

4.  Replication defect of moloney murine leukemia virus with a mutant reverse transcriptase that can incorporate ribonucleotides and deoxyribonucleotides.

Authors:  G Gao; S P Goff
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 5.  Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise.

Authors:  Stuart F J Le Grice
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

6.  dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases.

Authors:  Jürgen Beck; Maren Vogel; Michael Nassal
Journal:  Nucleic Acids Res       Date:  2002-04-01       Impact factor: 16.971

Review 7.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

8.  The cost of replication fidelity in human immunodeficiency virus type 1.

Authors:  Victoria Furió; Andrés Moya; Rafael Sanjuán
Journal:  Proc Biol Sci       Date:  2007-01-22       Impact factor: 5.349

9.  Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase.

Authors:  Kamalendra Singh; Bruno Marchand; Karen A Kirby; Eleftherios Michailidis; Stefan G Sarafianos
Journal:  Viruses       Date:  2010-02-11       Impact factor: 5.048

10.  Detecting allosteric sites of HIV-1 reverse transcriptase by X-ray crystallographic fragment screening.

Authors:  Joseph D Bauman; Disha Patel; Chhaya Dharia; Marc W Fromer; Sameer Ahmed; Yulia Frenkel; R S K Vijayan; J Thomas Eck; William C Ho; Kalyan Das; Aaron J Shatkin; Eddy Arnold
Journal:  J Med Chem       Date:  2013-02-20       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.